Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 118.81
-1.07 (-0.89%)
May 1, 2026, 3:35 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.17 billion as of May 1, 2026. Its market cap has increased by 224.77% in one year.
Market Cap
1.17B
Enterprise Value
1.08B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
118.81
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.17B, an increase of 2,099.82%. That is a compound annual growth rate of 80.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 1.17B | 36.44% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 600.89M |
| Satellos Bioscience | 216.85M |
| Helix BioPharma | 154.28M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 61.45M |
| NurExone Biologic | 50.63M |
| Medicenna Therapeutics | 47.55M |